Drawing for SIMPLIFY INFUSION PROCESS

USPTO serial 85042982

SIMPLIFY INFUSION PROCESS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
MICHELI, ANGELA M
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SIMPLIFY INFUSION PROCESS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Gerald T. Shekleton

LAURIE A HAYNIE HUSCH BLACKWELL SANDERS LLP WELSH & KATZ120 S RIVERSIDE PLZ FL 22CHICAGO, IL 60606-3912UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
044Medical services; Performing diagnosis of diseases; Medical testing for diagnostic or treatment purposes; Treatment of infections with oral and intravenous medications; medical services, namely, providing infusion therapy services; nursing services; infusion management, namely, administering of intravenous drugs, food and hydration through infusion therapyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 11, 2012MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 11, 2012ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 8, 2011NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 26, 2011TMBNTTAB RELEASE CASE TO TRADEMARKS—
Sep 26, 2011OP.TOPPOSITION TERMINATED NO. 999999—
Sep 26, 2011OP.DOPPOSITION DISMISSED NO. 999999—
Nov 22, 2010OP.IOPPOSITION INSTITUTED NO. 999999—
Nov 22, 2010OPPFOPPOSITION PAPERS RECEIVED AT TTAB—
Oct 26, 2010NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 26, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 17, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 15, 2010ALIEASSIGNED TO LIE—
Sep 5, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 3, 2010XAECEXAMINER'S AMENDMENT ENTERED—
Sep 3, 2010GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 3, 2010GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 3, 2010CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 3, 2010XAECEXAMINER'S AMENDMENT ENTERED—
Sep 3, 2010GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 3, 2010GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 3, 2010CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 30, 2010DOCKASSIGNED TO EXAMINER—
May 25, 2010NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 22, 2010NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance